Header cover image

Egyptian (OMX) Pharma Industry Analysis

UpdatedOct 30, 2023
DataAggregated Company Financials
Companies11
  • 7D0.6%
  • 3M12.0%
  • 1Y20.1%
  • YTD-0.7%

Over the last 7 days, the Pharma industry has risen 3.7%, driven by gains from Nile for Pharmaceuticals and Chemical Industries of 11%. In the last 12 months, the industry was up 21%. As for the next few years, earnings are expected to grow by 27% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Oct 2023ج.م15.2bج.م15.4bج.م1.9b6.2x7.8x1x
Wed, 27 Sep 2023ج.م14.2bج.م15.9bج.م2.0b7.1x7x0.9x
Fri, 25 Aug 2023ج.م13.7bج.م15.8bج.م2.1b7.2x6.5x0.9x
Sun, 23 Jul 2023ج.م13.6bج.م15.6bج.م2.1b7x6.4x0.9x
Tue, 20 Jun 2023ج.م13.9bج.م16.2bج.م2.2b5.4x6.3x0.9x
Thu, 18 May 2023ج.م13.4bج.م16.2bج.م2.4b4x5.6x0.8x
Sat, 15 Apr 2023ج.م14.5bج.م16.2bج.م2.4b5.2x6x0.9x
Mon, 13 Mar 2023ج.م13.9bج.م15.7bج.م2.3b5.3x6.1x0.9x
Wed, 08 Feb 2023ج.م14.7bج.م15.6bج.م2.3b5.4x6.4x0.9x
Fri, 06 Jan 2023ج.م15.2bج.م15.6bج.م2.3b5.5x6.7x1x
Sun, 04 Dec 2022ج.م14.4bج.م15.2bج.م2.2b4.4x6.6x0.9x
Tue, 01 Nov 2022ج.م12.9bج.م15.1bج.م2.2b5.1x5.9x0.9x
Thu, 29 Sep 2022ج.م12.7bج.م15.1bج.م2.2b4.7x5.9x0.8x
Sat, 27 Aug 2022ج.م13.0bج.م14.3bج.م2.0b5.7x6.4x0.9x
Mon, 25 Jul 2022ج.م12.2bج.م14.1bج.م1.9b5.6x6.3x0.9x
Wed, 22 Jun 2022ج.م12.0bج.م13.9bج.م1.9b5.7x6.4x0.9x
Fri, 20 May 2022ج.م11.9bج.م11.9bج.م1.7b5.6x7.2x1x
Sun, 17 Apr 2022ج.م12.3bج.م11.7bج.م1.7b5.5x7.4x1x
Tue, 15 Mar 2022ج.م12.7bج.م13.7bج.م1.8b6.4x6.9x0.9x
Thu, 10 Feb 2022ج.م13.5bج.م13.3bج.م1.8b6.6x7.4x1x
Sat, 08 Jan 2022ج.م13.7bج.م13.3bج.م1.8b6.4x7.6x1x
Mon, 06 Dec 2021ج.م12.8bج.م13.2bج.م1.8b5.9x7.1x1x
Wed, 03 Nov 2021ج.م12.3bج.م12.9bج.م1.8b5.3x7x0.9x
Fri, 01 Oct 2021ج.م13.0bج.م12.9bج.م1.8b5.4x7.3x1x
Sun, 29 Aug 2021ج.م13.7bج.م13.0bج.م1.8b5.5x7.7x1.1x
Mon, 05 Jul 2021ج.م13.3bج.م13.0bج.م1.8b5.2x7.4x1x
Thu, 08 Apr 2021ج.م12.9bج.م12.6bج.م1.7b5.5x7.7x1x
Sun, 10 Jan 2021ج.م12.5bج.م12.2bج.م1.6b6x7.7x1x
Price to Earnings Ratio

7.8x


Total Market Cap: ج.م12.5bTotal Earnings: ج.م1.6bTotal Revenue: ج.م12.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7x202120222023
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 7.8x which is higher than its 3-year average PE of 7.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.96x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 6.5% per year over the last three years.
  • Revenues for these companies have grown 8.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market4.22%
Healthcare2.05%
Pharma0.62%
Pharma0.62%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CPCI Kahira Pharmaceuticals & Chemical Industriesج.م45.4611.6%
+ج.م70.8m
-1.1%PE7x
NIPH Nile for Pharmaceuticals and Chemical Industriesج.م57.9810.9%
+ج.م57.9m
63.3%PE6.2x
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)Eج.م1.591.7%
+ج.م40.2m
-10.7%PE10.7x
ADCI Arab Drugج.م62.493.9%
+ج.م14.2m
33.6%n/a
SIPC Sabaa International Company for Pharmaceutical and Chemical Industryج.م0.767.2%
+ج.م12.8m
-26.2%PE39.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News